Vitamin C: are the recommended doses really enough?

Introductory Note

This article was previously published and has been updated according to scientific and divulgative criteria. The information presented here is for informational purposes only and does not replace medical advice.

In Brief

• Vitamin C is essential for collagen synthesis and stability, playing a central role in tissue healing.
• A modern reanalysis of a 1944 experiment suggests that the minimum dose to preserve scar strength might be higher than traditional WHO recommendations.
• Pharmacokinetics show that the dose-plasma relationship is not linear: moderate doses (100–200 mg/day) saturate body compartments differently compared to very high doses or intravenous administrations.
• International guidelines differ: some European agencies indicate higher values than those historically adopted by the WHO.
• Evidence on supplementation and clinical healing suggests potential benefits, but the quality of clinical studies is variable and requires cautious interpretation.

Abstract: What Does Science Say?

Vitamin C (ascorbic acid) is an essential nutrient that acts as a cofactor in key enzymatic reactions for collagen formation and as an antioxidant. Classic studies on scurvy defined minimum thresholds to prevent the disease, but modern reanalyses of historical data indicate that the amount needed to maintain full tissue function (scar strength) can be significantly higher. Human pharmacokinetics show that plasma saturation occurs at relatively low doses compared to pharmacological doses invoked in some clinical contexts; however, the response depends on exposure duration, initial nutritional status, and administration form. Experimental evidence supports the biological role of ascorbic acid in healing, but clinical trials on the effectiveness of supplementation for wound healing remain limited and conflicting. It is therefore necessary to distinguish between mechanistic evidence, observational data, and causal clinical evidence, and to interpret the need for supplementation beyond an adequate diet with caution.

History and Context: The Sorby Experiment and Modern Reanalysis

In the 1940s, an experiment conducted at the Sorby Research Institute (the “shipwreck experiment”) was often cited to establish the minimum daily dose of vitamin C useful for preventing scurvy. Recently, a statistical reanalysis of the individual data from that trial highlighted interpretive aspects overlooked in the past: modern analysis shows a dose-response relationship between average vitamin C intake and scar strength, suggesting that average intakes around 95–100 mg/day might be necessary to preserve normal scar strength in the majority of the population, compared to the historically reported minimum values. This reanalysis also emphasizes that correcting a deficiency state may require longer times and higher doses than previously hypothesized, with possible persistence of functional deficits even after short-term supplementation [1].

What has changed, in practice, compared to the past

The modern reinterpretation does not deny the historical value of the study, but highlights that the definition of a "minimum dose to avoid scurvy" does not automatically coincide with the amount needed to maintain optimal tissue integrity. In other words, preventing overt deficiency (scurvy) and maintaining optimal biological functions may require different thresholds: the former can be low, the latter higher. This element is crucial when reflecting on public nutritional recommendations and individual supplementation strategies [1].

Biological Mechanisms: Vitamin C, Collagen, and Healing

The most relevant biological function of vitamin C in the context of healing is its action as a cofactor for oxidases/oxygenases that hydroxylate proline and lysine residues in procollagen chains. These hydroxylations are necessary for the correct folding of the collagen triple helix and for the formation of cross-links that provide mechanical strength to scar tissue. Without adequate levels of ascorbic acid, collagen synthesis and stability are compromised, leading to reduced integrity of blood vessels and connective tissues [2].

Biological implications of deficiency

Prolonged deficiency manifests with typical clinical signs of scurvy: bleeding gums, capillary fragility, delayed healing, and increased susceptibility to lesions of connective structures. At the molecular level, vitamin C depletion reduces hydroxylase activity, alters procollagen secretion, and can influence local inflammatory and oxidative processes, which are essential for proper tissue repair [2].

Dose and Pharmacokinetics: How Vitamin C Behaves in the Body

The pharmacokinetics of vitamin C in healthy subjects show that the relationship between dose and plasma concentration is not linear. Increasing oral doses produce progressively attenuated plasma increases due to limits of intestinal absorption and rapid renal elimination: oral doses in the order of 100–200 mg/day tend to lead to "saturated" plasma levels in healthy individuals, while much higher doses do not indefinitely increase plasma concentration via oral administration. To achieve pharmacological plasma concentrations, intravenous administration is necessary [3][4].

Duration of exposure and repletion of tissue stores

Recovery from a state of depletion takes time: studies on deficiency situations document that moderate short-term supplementation may not be sufficient to completely normalize functional parameters such as scar strength. The history of exposure (duration and depth of deficiency) influences the speed and completeness of tissue repletion: in some cases, months of adequate intake are needed to restore functional normality [1][3].

Official Recommendations: Comparing Values and Their Interpretation

Nutritional recommendations are not uniform internationally. Some European bodies and scientific panels have indicated reference values that are, on average, higher than those historically reported by the WHO. Modern assessments of needs are based on pharmacokinetic evidence, functional outcomes, and the principle of satisfying the majority of the healthy population; for this reason, some European documents consider reference values in the order of tens of mg more than the minimum thresholds for scurvy prevention [5].

Interpreting thresholds: prevention vs. optimization

It is important to distinguish between: (a) the minimum dose to avoid overt deficiency disease; (b) the dose that maintains optimal biological functions. The former are significantly lower than the latter. Regulatory decisions take into account safety, available evidence, and dietary feasibility: this explains the variability of recommendations among different entities [5].

What it means in practice

For the general public, evidence indicates that vitamin C is fundamental for tissue health and healing. A diet rich in fruits and vegetables (citrus fruits, kiwi, bell peppers, broccoli, strawberries) is the safest and most recommended way to achieve amounts that saturate useful tissue compartments (often in the order of 100 mg/day or more, depending on the source). Mechanistic studies and systematic reviews suggest that, in deficient individuals or those at risk of deficiency, correcting vitamin status can improve tissue repair parameters; however, large-scale randomized clinical data remain limited and not always consistent [6][7].

For those considering the use of supplements: moderate daily doses (e.g., in the order of 100–200 mg) fall within the strategies used to achieve plasma concentrations considered optimal for many cellular functions; very high doses should be considered in specific clinical contexts and under medical supervision, especially for people with kidney conditions or other comorbidities [3][4].

Key points to remember

• Vitamin C is essential for collagen synthesis: its deficiency compromises scar strength and vascular integrity.
• A reanalysis of historical data indicates that the amount needed to preserve normal scar strength is likely higher than the minimum threshold to prevent scurvy [1].
• Pharmacokinetics show that plasma saturation is achieved with moderate doses; intravenous doses reach pharmacological levels not obtainable orally [3][4].
• Official recommendations vary: it is essential to distinguish between prevention of deficiency disease and optimization of tissue function [5].
• Clinical evidence suggests benefits in tissue healing, but the quality and number of human trials remain limited; clinical decisions must be based on individual assessment and professional advice [6][8].

Limitations of Evidence

The main limitations must be kept in mind: many relevant studies are observational or based on animal models; clinical trials are often small, with variable protocols (dose, duration, form of administration). The distinction between association and causality is crucial: observations linking higher plasma levels to better outcomes do not necessarily prove that additional supplementation improves outcomes if the subject was not deficient. Furthermore, the history of exposure and initial nutritional status condition the response to supplementation, complicating normative generalizations [6][7].

Editorial Conclusion

Current knowledge consolidates the fundamental role of vitamin C in collagen biology and tissue healing. Modern reanalyses of historical data push for a revision of simplistic interpretations that equated the minimum dose to avoid scurvy with the optimal dose for tissue function. For the public, the practical recommendation remains: prioritize a diet rich in fruits and vegetables; evaluate supplementation only when necessary or in the presence of conditions that increase requirements; and rely on a doctor for therapeutic choices or for high doses. Quality clinical research remains necessary to clarify if and when supplementation beyond an adequate diet provides measurable and lasting clinical benefits.

Editorial Transparency

This update was carried out following scientific integrity criteria: synthesis of peer-reviewed evidence, use of sources with verified DOIs, and distinction between biological mechanisms, observational data, and clinical evidence. No commercial references were used to write the text. [Information on author, reviewer, and conflicts of interest: [data not available]]

Editorial Note

Article originally published in the past and updated to reflect recent research and reanalyses. The text is for informational purposes only and does not replace a doctor's evaluation. For personal clinical questions, it is necessary to consult a healthcare professional.

Scientific Research

1. Philippe P. Hujoel, Margaux L. A. Hujoel. Vitamin C and scar strength: analysis of a historical trial and implications for collagen-related pathologies. American Journal of Clinical Nutrition. 2021. https://doi.org/10.1093/ajcn/nqab262
2. Johanna Myllyharju. Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biology. 2003. https://doi.org/10.1016/S0945-053X(03)00006-4
3. Mark Levine et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences. 1996. https://doi.org/10.1073/pnas.93.8.3704
4. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA, Levine M. Vitamin C pharmacokinetics: implications for oral and intravenous use. Annals of Internal Medicine. 2004. https://doi.org/10.7326/0003-4819-140-7-200404060-00010
5. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on Dietary Reference Values for vitamin C. EFSA Journal. 2013. https://doi.org/10.2903/j.efsa.2013.3418
6. Nicholas N. DePhillipo et al. Efficacy of Vitamin C Supplementation on Collagen Synthesis and Oxidative Stress After Musculoskeletal Injuries: A Systematic Review. Orthopaedic Journal of Sports Medicine. 2018. https://doi.org/10.1177/2325967118804544
7. B. Mohammed et al. Vitamin C promotes wound healing through novel pleiotropic mechanisms. International Wound Journal. 2016. https://doi.org/10.1111/iwj.12484
8. Anitra C. Carr, Silvia Maggini. Vitamin C and Immune Function. Nutrients. 2017. https://doi.org/10.3390/nu9111211